Citatuzumab bogatox

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Citatuzumab bogatox
Monoclonal antibody
Type Fab fragment
Source Humanized (from mouse)
Target TACSTD1
Clinical data
ATC code
  • none
CAS Number
  • none
Chemical and physical data
Formula C3455H5371N921O1060S18
Molar mass 77.3 kg/mol
 NYesY (what is this?)  (verify)

Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]


  1. ^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
  2. ^ Viventia Biotech Inc.: VB6-845